drugset / Trial / NCT00445354

Randomized Controlled Clinical Trial of Cinnamon to Lower Hemoglobin A1c

NCT00445354

Phase 3 Completed 109 enrolled Eglin AFB Regional Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will randomize diabetics with hemoglobin A1c greater than 7.0 to receive either cinnamon plus usual care or usual care alone. Hemoglobin A1c will be measured at intake and after 90 days.

Timeline

Start
2007-03
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cinnamon Unknown 1 g

Indications